MIS Healthcare expands oncology and nuclear medicine portfolio
Medical imaging distributor MIS Healthcare has added products from Xiel Limited to its oncology portfolio. A specialist in nuclear medicine, radiotherapy and diagnostic radiology solutions, Xiel brings expertise in radiotherapy and nuclear medicine, working with global partners to improve efficiency and quality for healthcare providers.
Through this acquisition, MIS Healthcare expands its portfolio, offering a broader range of solutions across the UK and Ireland.
Xiel MD Jack Knight said: “We are excited to join forces with MIS Healthcare, an organisation equally committed to advancing healthcare technology and exceptional customer service. This partnership allows us to combine expertise and drive new standards in the industry.”
MIS Healthcare director Mark O’Herlihy added: “By integrating Xiel’s specialised knowledge with MIS Healthcare’s extensive radiotherapy portfolio, we will accelerate innovation and deliver exceptional value to the healthcare community.”
Read this report on page 14 of the May 2025 issue of RAD Magazine.
